Dodge & Cox
Source: SEC Form 13F · as of Mar 2026Dodge & Cox holds 7 biotech & pharma companies tracked by BioSniper, totaling $14.10B in value as of Mar 2026 (SEC Form 13F).
Companies held
7
Total value held
$14.10B
BioSniper AIPage evidence connected
Prepared research question
What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 4,458,238 | $3.44B |
| GILDGILEAD SCIENCES, INC. | 24,250,826 | $3.38B |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 58,662,974 | $3.24B |
| SNYSanofi | 29,504,632 | $1.42B |
| INCYIncyte Corp. | 12,252,356 | $1.15B |
| BMRNBIOMARIN PHARMACEUTICAL INC | 14,561,759 | $822.6M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,929,253 | $638.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.